Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue, net $ 9,826 $ 7,923
Cost of revenue 3,848 3,265
Gross profit 5,978 4,658
Operating expenses:    
Sales and marketing 2,342 2,200
Research and development 149 231
General and administrative 2,494 2,886
Acquisition related amortization expense 318 318
Total operating expenses 5,303 5,635
Operating income (loss) from continuing operations 675 (977)
Interest accretion expense (35) (121)
Note payable interest (225) (180)
Other income, net 19 161
Income (loss) from continuing operations before tax 434 (1,117)
Provision for income taxes 4 18
Income (loss) from continuing operations 430 (1,135)
Loss from discontinued operations, net of tax (79) (1,112)
Net income (loss) $ 351 $ (2,247)
Basic income (loss) per share of common stock:    
From continuing operations $ 0.10 $ (0.27)
From discontinued operations (0.02) (0.26)
Net income (loss) per basic and diluted share of common stock 0.08 (0.53)
Diluted income (loss) per share of common stock:    
From continuing operations 0.10 (0.27)
From discontinued operations (0.02) (0.26)
Net income (loss) per basic and diluted share of common stock $ 0.08 $ (0.53)
Weighted average number of common shares and common share equivalents outstanding:    
Basic 4,307 4,208
Diluted 4,308 4,208